Agile Bio
Latest round
- Series C
Last raised
- Feb 2025
Total raised
- $14M
Investors
- 10
About Agile Bio
Founded in 2020 and based in Suzhou, China, Agile Bio is a bioelectronics technology company that focuses on the research and development of medical instruments and magnetic solid-phase materials. As of 2023, the company has obtained or applied for more than 60 intellectual property rights including invention patents, utility model patents, and software copyrights. It has passed ISO9001 quality management system certification. The company's main products include special chromatographic separation and adsorption materials, mSPE fully automatic magnetic bead extraction technology and products, etc. Special chromatographic separation and adsorption materials include organically bonded silica gel, protein limited ingress, core-shell, magnetic solid-phase extraction, and other chromatographic media. The company’s revenue is generated by providing new materials and automation systems in the fields of biomedicine, clinical testing, food testing, etc.
Who invested in Agile Bio
10 investors across 3 rounds
See all investors in Agile Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Agile Bio
Who invested in Agile Bio?
Agile Bio has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Agile Bio raised?
Agile Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Agile Bio last raise money?
Agile Bio's most recent round on record is a Series C, in Feb 2025.
What does Agile Bio do?
Founded in 2020 and based in Suzhou, China, Agile Bio is a bioelectronics technology company that focuses on the research and development of medical instruments and magnetic solid-phase materials.
Where is Agile Bio headquartered?
Agile Bio is headquartered in Suzhou, China.
Which VCs invest in companies like Agile Bio?
Among active investors with capital left to deploy, Hui Hua Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back materials companies at Agile Bio's stage. Their profiles are linked below.
VCs backing materials startups at Series C
Raising like Agile Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.